AYTU Aytu BioScience Inc
Company Analysis
Latest News
🟢 Aytu BioScience is trading 5.47% up today amid a 2.10% gain in biotech ETF XBI
Aytu BioScience is trading 5.47% higher at $2.12 on October 21, 2026, with biotech-sector strength a possible context for the move. - Biotech ETF XBI is up...
🟢 Aytu BioScience is trading 6% up amid biotech sector gains
Aytu BioScience is trading at $2.10, up 5.53% on October 19, 2026, alongside a 2.09% biotech-sector gain; no direct link between the sector move and the stock...
🟢 Aytu BioScience is trading 6.5% up on October 16, 2026 — with no specific explanation reported
Aytu BioScience is trading at $2.14, up 6.47%, with no specific catalyst identified. - The company’s press-release page shows no release dated October 16, and...
🟢 Aytu BioScience is trading 6.8% up in after-hours trading
Aytu BioScience is trading 6.8% higher at $2.16 in after-hours trading; reviewed sources showed no clear company-specific explanation. - The stock closed at...
🟢 Aytu BioScience is trading 9.25% up in after-hours trading as the reason remains unclear
Aytu BioScience is trading at $2.24, up 9.25% in after-hours trading; the reason for the October 7 rise remains unclear. - No company-specific announcement...
🟢 Aytu BioScience is trading 5% up in pre-market — no specific overnight catalyst identified
Aytu BioScience is trading 5.41% higher at $2.32 in pre-market on September 30, 2026, after moving from the September 29 close of $2.20; no specific overnight...
🔴 Aytu BioScience is trading 6.1% down in pre-market as Nasdaq and S&P 500 decline
Aytu BioScience is trading at $2.14, down 6.14%, alongside a risk-off pre-market, with the Nasdaq Composite down 0.93% and S&P 500 down 0.52%. - No new...
🔴 Aytu BioScience is trading 5% down in after-hours trading as full-year revenue and adjusted EBITDA declined
Aytu BioScience is trading at $2.16, down 5.46%, as investors weigh mixed fiscal 2026 results. • Q4 revenue rose 6.4% to $16.1 million; full-year revenue fell...
🟢 Aytu BioScience is trading 6.73% up in pre-market after EXXUA generated $3.9 million in first-full-quarter revenue
Aytu BioScience is trading 6.73% up at $2.38 after September 22, 2026 fiscal fourth-quarter results highlighted EXXUA’s commercial momentum. - EXXUA generated...
Aytu BioPharma's fourth quarter revenue of $16.1M rises 6% as EXXUA launch offsets ADHD decline
Aytu BioPharma reported fourth quarter fiscal 2026 revenue of $16.1 million, a 6.4% increase from the prior year, though results fell significantly short of...
🟢 Aytu BioScience is trading 6% up today ahead of fiscal 2026 results after market close
Aytu BioScience is trading 5.88% up at $2.25 as investors position ahead of its fiscal 2026 full-year and fourth-quarter results, scheduled after the market...
Aytu BioScience Inc Q2 2026 Earnings Preview: What Analysts Expect on September 22, 2026
Aytu BioScience is expected to report a Q2 2026 consensus revenue of $24.52 million and an EPS loss of $0.22, with the current stock price of $2.85 trading...
🟢 Aytu BioScience is trading 7.5% up today as biotech stocks rally
Aytu BioScience is trading $2.15 (+7.50%) as biotech stocks rally. • The stock closed at $2.00 on September 17, 2026; XBI is up 2.55%, supporting risk...
🟢 Aytu BioScience is trading 9.12% up today amid a broad market rebound
Aytu BioScience is trading 9.12% up now at $2.15, after closing at $1.97 on September 16, 2026, with the move appearing aligned with a broader risk-on...
🔴 Aytu BioScience is trading 5% down today amid a broad biotech-sector selloff
Aytu BioScience is trading 5.03% down now at $1.89 after closing at $1.99 on September 15, 2026, amid a broader biotech-sector selloff. - No verified...
🔴 Aytu BioScience is trading 7.04% down in pre-market with no clear catalyst identified
Aytu BioScience is trading 7.04% down at $1.85 after closing at $1.99 on September 15, 2026, with no clear company-specific catalyst identified. - No verified...
🔴 Aytu BioScience is trading 8.3% down in after-hours trading with no clear company-specific catalyst identified
Aytu BioScience is trading 8.3% down now at $1.82 after falling from the September 15, 2026 regular-session close of $1.99 amid broad market risk-off...
🟢 Aytu BioScience is trading 8.4% up in after-hours trading with no clear catalyst
Aytu BioScience is trading 8.4% up at $2.16 in after-hours trading, with no reliable company-specific announcement, earnings release, filing, or late-breaking...
🟢 Aytu BioScience is trading 5.26% up today amid biotech-sector strength
Aytu BioScience is trading 5.26% up at $2.40, with the advance appearing primarily tied to biotechnology-sector strength. - No clear company-specific...
🔴 Aytu BioScience is trading 6% down today on no clear news catalyst
Aytu BioScience is trading approximately 6% down today at $2.04 on no clear news catalyst, lagging behind a broadly flat market and a strong biotech sector. •...